105 related articles for article (PubMed ID: 18339854)
1. Rad6B is a positive regulator of beta-catenin stabilization.
Shekhar MP; Gerard B; Pauley RJ; Williams BO; Tait L
Cancer Res; 2008 Mar; 68(6):1741-50. PubMed ID: 18339854
[TBL] [Abstract][Full Text] [Related]
2. Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin.
Gerard B; Sanders MA; Visscher DW; Tait L; Shekhar MP
Biochim Biophys Acta; 2012 Oct; 1823(10):1686-96. PubMed ID: 22705350
[TBL] [Abstract][Full Text] [Related]
3. Essential role of T-cell factor/beta-catenin in regulation of Rad6B: a potential mechanism for Rad6B overexpression in breast cancer cells.
Shekhar MP; Tait L; Gerard B
Mol Cancer Res; 2006 Oct; 4(10):729-45. PubMed ID: 17050667
[TBL] [Abstract][Full Text] [Related]
4. Rad6B acts downstream of Wnt signaling to stabilize β-catenin: Implications for a novel Wnt/β-catenin target.
Gerard B; Tait L; Nangia-Makker P; Shekhar MP
J Mol Signal; 2011 Jul; 6():6. PubMed ID: 21767405
[TBL] [Abstract][Full Text] [Related]
5. RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling.
Sarma A; Gajan A; Kim S; Gurdziel K; Mao G; Nangia-Makker P; Shekhar MPV
Am J Pathol; 2021 Feb; 191(2):368-384. PubMed ID: 33181138
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization.
Sanders MA; Brahemi G; Nangia-Makker P; Balan V; Morelli M; Kothayer H; Westwell AD; Shekhar MPV
Mol Cancer Ther; 2013 Apr; 12(4):373-83. PubMed ID: 23339190
[TBL] [Abstract][Full Text] [Related]
7. RAD6B overexpression confers chemoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response.
Lyakhovich A; Shekhar MP
Oncogene; 2004 Apr; 23(17):3097-106. PubMed ID: 14981545
[TBL] [Abstract][Full Text] [Related]
8. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
9. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
10. Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization.
Gajan A; Martin CE; Kim S; Joshi M; Michelhaugh SK; Sloma I; Mittal S; Firestine S; Shekhar MPV
Cells; 2019 Nov; 8(11):. PubMed ID: 31683936
[TBL] [Abstract][Full Text] [Related]
11. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
12. Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells.
Laezza C; D'Alessandro A; Paladino S; Maria Malfitano A; Chiara Proto M; Gazzerro P; Pisanti S; Santoro A; Ciaglia E; Bifulco M;
Eur J Cancer; 2012 Nov; 48(16):3112-22. PubMed ID: 22425263
[TBL] [Abstract][Full Text] [Related]
13. Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response.
Shekhar MP; Biernat LA; Pernick N; Tait L; Abrams J; Visscher DW
Med Oncol; 2010 Jun; 27(2):466-73. PubMed ID: 19466589
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
15. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
16. Ube2s stabilizes β-Catenin through K11-linked polyubiquitination to promote mesendoderm specification and colorectal cancer development.
Li Z; Wang Y; Li Y; Yin W; Mo L; Qian X; Zhang Y; Wang G; Bu F; Zhang Z; Ren X; Zhu B; Niu C; Xiao W; Zhang W
Cell Death Dis; 2018 May; 9(5):456. PubMed ID: 29674637
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
Rios-Doria J; Kuefer R; Ethier SP; Day ML
Cancer Res; 2004 Oct; 64(20):7237-40. PubMed ID: 15492240
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hydroquinone on the expression of ubiquitin-conjugating enzyme Rad6B in human L-02 hepatic cells].
Hu G; Zhuang Z; Yang J; Huang H
Wei Sheng Yan Jiu; 2009 May; 38(3):352-4. PubMed ID: 19548583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
